Digital monitoring of cognitive and motor symptoms in Huntington’s disease: preliminary longitudinal findings from the GENERATION HD1 study of tominersen

The Roche HD Digital Monitoring Platform has been deployed across several studies in patients with HD, including GENERATION HD1, GEN-PEAK, HD Natural History Study, OLE, GEN-EXTEND and Digital-HD. This presentation outlines what the Roche HD Digital Monitoring Platform is, the broader context of the digital data collection in GENERATION HD1 and what this digital data tells us about tominersen and the Roche HD Digital Monitoring Platform.

{{assetTitle}}

Authors {{assetAuthors}}

Published date{{formattedPublishDate}}

{{assetDescription}}

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.